Goldman Sachs Raises Estimates On Groupon (GRPN) after Solid Q4 Results
Get Alerts GRPN Hot Sheet
Price: $21.87 --0%
Rating Summary:
14 Buy, 16 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 15 | New: 6
Rating Summary:
14 Buy, 16 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 15 | New: 6
Join SI Premium – FREE
Goldman Sachs reiterated their Buy rating and $29 price target on Groupon, Inc. (NASDAQ: GRPN) following "solid" Q4 results.
The firm noted 4Q results exceeded consensus by $28 million in billings, $33 million in revenues, and $21 million in CSOI on strong billings growth, a higher-than -expected take rate, and reduced marketing expenditures.
Based on the strength in billings growth and marketing leverage, Goldman is revising 2012 estimates. 2012 revenue, CSOI and PF EPS estimates move from $2.2 bn, $275 mn and $0.31 to $2.5 bn, $388 mn and $0.40. 2013 estimates move from $2.9 bn, $804 mn, $0.80 to $3.0 bn, $ 863mn, $0.85, while 2014E are $3.8 bn, $1.1 bn, and $1.19.
For an analyst ratings summary and ratings history on Groupon, Inc. click here. For more ratings news on Groupon, Inc. click here.
Shares of Groupon, Inc. closed at $24.58 yesterday.
The firm noted 4Q results exceeded consensus by $28 million in billings, $33 million in revenues, and $21 million in CSOI on strong billings growth, a higher-than -expected take rate, and reduced marketing expenditures.
Based on the strength in billings growth and marketing leverage, Goldman is revising 2012 estimates. 2012 revenue, CSOI and PF EPS estimates move from $2.2 bn, $275 mn and $0.31 to $2.5 bn, $388 mn and $0.40. 2013 estimates move from $2.9 bn, $804 mn, $0.80 to $3.0 bn, $ 863mn, $0.85, while 2014E are $3.8 bn, $1.1 bn, and $1.19.
For an analyst ratings summary and ratings history on Groupon, Inc. click here. For more ratings news on Groupon, Inc. click here.
Shares of Groupon, Inc. closed at $24.58 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oppenheimer Downgrades Legend Biotech Corp. (LEGN) to Perform, 'CEO/Partnership/Competition Overhangs to Cap Upside'
- Sea Ltd. (SE) PT Raised to $175 at Benchmark on Robust Growth
- Northland Upgrades Similarweb Ltd (SMWB) to Outperform
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS ViewRelated Entities
Goldman SachsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share